The Tough Tech problem we are solving
Modern medicine often relies on treatments that patch or replace, rather than repair and restore. For patients suffering from tendon injuries, heart valve degeneration, or chronic urological conditions, current “one-size-fits-all” therapies fail to account for individual biology and often lead to long recovery times, reinjury, and limited outcomes. These inefficiencies drive billions in healthcare costs each year while leaving patients without regenerative solutions that can truly heal the body. The industry urgently needs adaptive, biologically attuned technologies that enable the body to rebuild itself rather than depend on temporary mechanical or pharmaceutical fixes.
About our solution
Smartweave is pioneering a new era of regenerative therapeutics designed to accelerate healing and restore health at the cellular level. Through platforms such as Heraweave™, Orthoweave™, and Cardioweave™, the company integrates advanced biologics, AI-driven optimization, and proprietary scaffold technologies to promote natural tissue regeneration across cardiology, orthopedics, and urology. Supported by leading institutions like Stanford Medicine and Cedars-Sinai, and backed by over $12 million in NIH and California Institute of Regenerative Medicine grants, Smartweave’s scientifically validated approach fuses innovation and precision to transform recovery outcomes, reduce complications, and redefine what it means for the body to heal itself.